A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse (Q34527972)

2 August 2017

1 reference

title

A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse (English)

1 reference

2 August 2017

Linda P Dwoskin

1

1 reference

2 August 2017

Peter A Crooks

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

2 August 2017

published in

Biochemical Pharmacology

1 reference

2 August 2017

volume

63

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

89-98

1 reference

Über die Alkaloide der Lobelia-Pflanze. I

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Die Lobelia-Alkaloide. II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Relations between structure and nicotine-like activity: X-ray crystal structure analysis of (-)-cytisine and (-)-lobeline hydrochloride and a comparison with (-)-nicotine and other nicotine-like compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

The comparative binding characteristics of nicotinic ligands and their pharmacology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Hyperalgesic and analgesic actions of morphine, U50-488, naltrexone, and (-)-lobeline in the rat brainstem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Effects of lobeline, a nicotinic receptor agonist, on learning and memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Epibatidine binding sites and activity in the spinal cord

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Nociceptive and antinociceptive responses to intrathecally administered nicotinic agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Nicotine self-administration in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Acquisition of nicotine self-administration in rats: the effects of dose, feeding schedule, and drug contingency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Nicotine self-administration in rats: strain and nicotine pre-exposure effects on acquisition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Nornicotine is self-administered intravenously by rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Reinforcing effects of nicotinic compounds: intravenous self-administration in drug-naive mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

The effects of nicotine on locomotor activity in non-tolerant and tolerant rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Receptor mechanisms of nicotine-induced locomotor hyperactivity in chronic nicotine-treated rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Dopaminergic mechanisms in the locomotor stimulant effects of nicotine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Pharmacologic characterization of nicotine-induced conditioned place preference.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Nicotine-induced place preferences following prior nicotine exposure in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Nicotine-induced conditioned place preference and conditioned place aversion in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Further studies on nicotine-induced conditioned place preference in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Dissociations between the locomotor stimulant and depressant effects of nicotinic agonists in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Effects of nicotine, nicotine monomethiodide, lobeline, chlordiazepoxide., meprobamate and caffeine on a discrimination task in laboratory rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Nicotine as a discriminative cue in rats: Inability of related drugs to produce a nicotine-like cueing effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Stereospecific nicotine receptors on rat brain membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Behavioural and pharmacokinetic studies on nicotine, cytisine and lobeline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

The effects of various "nicotine-like" agents in the cat superior cervical ganglion in situ.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

A comparison of lobeline and nicotine at the frog neuromuscular junction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Receptor desensitization by lobeline and nicotine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

An attempt to distinguish between the actions of neuromuscular blocking drugs on the acetylcholine receptor and on its associated ionic channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Carotid receptors and bronchomotor responses. Effects of cigarette smoke, lobeline, and cyanide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

ACTION OF LOBELINE ON PULMONARY ARTERY MECHANORECEPTORS OF THE CAT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Blocking of tetraethylammonium on lobelin-induced thoracic pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Lobeline and Reduction of Cigarette Smoking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

In vivo specific binding of [3H]1-nicotine in the mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Dissociation of the apparent relationship between nicotine tolerance and up-regulation of nicotinic receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Regulation of brain nicotinic receptors by chronic agonist infusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Upregulation of nicotinic receptors following continuous infusion of nicotine is brain-region-specific

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

The Regulation of Hippocampal Nicotinic Acetylcholine Receptors (nAChRs) After a Protracted Treatment with Selective or Nonselective nAChR Agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

[125/123I]IPH: a radioiodinated analog of epibatidine for in vivo studies of nicotinic acetylcholine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Pharmacological evaluation of [11C]A-84543: an enantioselective ligand for in vivo studies of neuronal nicotinic acetylcholine receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Neuronal nicotinic receptor beta2 and beta4 subunits confer large differences in agonist binding affinity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Activation and inhibition of the human alpha7 nicotinic acetylcholine receptor by agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Stereoselective nicotine-induced release of dopamine from striatal synaptosomes: concentration dependence and repetitive stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine and other nicotinic antagonists administered in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Locomotor activation and dopamine release produced by nicotine and isoarecolone in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Regulation of dopamine release by presynaptic nicotinic receptors in rat striatal slices: Effect of nicotine in a low concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Dopamine efflux from striatum after chronic nicotine: evidence for autoreceptor desensitization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Effects of lobeline and dimethylphenylpiperazinium iodide (DMPP) on N-methyl-D-aspartate (NMDA)-evoked acetylcholine release in vitro: evidence for a lack of involvement of classical neuronal nicotinic acetylcholine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Striatal application of nicotine, but not of lobeline, attenuates dopamine release in freely moving rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Characterization of nicotinic receptors involved in the release of noradrenaline from the hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Lobeline and structurally simplified analogs exhibit differential agonist activity and sensitivity to antagonist blockade when compared to nicotine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

The influence of lobeline on nucleus accumbens dopamine and locomotor responses to nicotine in nicotine-pretreated rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Lobeline inhibits nicotine-evoked [(3)H]dopamine overflow from rat striatal slices and nicotine-evoked (86)Rb(+) efflux from thalamic synaptosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Pharmacological characterization of nicotinic receptor-mediated acetylcholine release in rat brain--an in vivo microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Nicotine-stimulated release of [3H]norepinephrine from fetal rat locus coeruleus cells in culture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

The regionalization of [3H]dihydrotetrabenazine binding sites in the mouse brain and its relationship to the distribution of monoamines and their metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Binding of α-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecific

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

A molecular analysis of vesicular amine transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Dynamic storage of dopamine in rat brain synaptic vesicles in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

The pharmacological and anatomical substrates of the amphetamine response in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

The neural substrates for the motor-activating properties of psychostimulants: a review of recent findings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Localization of drug reward mechanisms by intracranial injections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Dopaminergic A10 neurones are involved in cognitive functions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Destruction of dopaminergic nerve terminals in nucleus accumbens: Effect on d-amphetamine self-administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Disruption of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Molecular Mechanisms of Drug Reinforcement and Addiction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Conditioned place preference from intra-accumbens but not intra-caudate amphetamine injections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Self-injection of amphetamine directly into the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

The reserpine-sensitive dopamine pool mediates (+)-amphetamine-conditioned reward in the place preference paradigm.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Bilateral intra-accumbens self-administration of d-amphetamine: antagonism with intra-accumbens SCH-23390 and sulpiride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Dopamine and noradrenaline transport into subcellular vesicles of the striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Phencyclidine: effect on the accumulation of 3H-dopamine in synaptic vesicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Comparison of the release of [3H]dopamine from isolated corpus striatum by amphetamine, fenfluramine and unlabelled dopamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Inhibition of monoamine oxidase by amphetamine and related compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

In vivo monoamine oxidase inhibition by d-amphetamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Dopamine transport: pharmacological distinction between the synaptic membrane and the vesicular transporter in rat striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Synaptic vesicular monoamine transporter expression: distribution and pharmacologic profile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Lobeline: structure-affinity investigation of nicotinic acetylcholinergic receptor binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Tetrabenazine has properties of a dopamine receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Vesicular monoamine transport inhibitors. Novel action at calcium channels to prevent catecholamine secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

Lobeline displaces [3H]dihydrotetrabenazine binding and releases [3H]dopamine from rat striatal synaptic vesicles: comparison with d-amphetamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900899-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-2952(01)00899-1

1 reference

2 August 2017

1 reference